AZN CIK: 901832

AstraZeneca PLC

  • United Kingdom
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
26.2
FY22:
22.6
FY23:
25.1
FY24:
25.8
FY25:
28.7
(positive)
Change from FY21 to FY25
billions USD
FY21:
79.1
FY22:
73.9
FY23:
76.1
FY24:
78.2
FY25:
85.4
Total assets
Change from FY21 to FY25
billions USD
FY21:
105
FY22:
96.5
FY23:
101
FY24:
104
FY25:
114

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
22.6
FY22:
26.3
FY23:
30.5
FY24:
27.9
FY25:
30.6
(negative)
Change from FY21 to FY25
billions USD
FY21:
43.5
FY22:
33.1
FY23:
31.4
FY24:
35.3
FY25:
34.7
(positive)
Change from FY21 to FY25
billions USD
FY21:
39.3
FY22:
37.1
FY23:
39.2
FY24:
40.9
FY25:
48.7
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
105
FY22:
96.5
FY23:
101
FY24:
104
FY25:
114

All amounts in billions USD Data source:SEC EDGAR